QTc prolongation in COVID‐19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: a systematic review and meta‐analysis

C Diaz‐Arocutipa, A Brañez‐Condorena… - … and Drug Safety, 2021 - Wiley Online Library
Purpose Hydroxychloroquine, chloroquine, azithromycin, and lopinavir/ritonavir are drugs
that were used for the treatment of coronavirus disease 2019 (COVID‐19) during the early …

Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis

J Deng, F Zhou, K Heybati, S Ali, QK Zuo, W Hou… - Future …, 2022 - Taylor & Francis
Aims: To evaluate the efficacy and safety of hydroxychloroquine/chloroquine, with or without
azithromycin, in treating hospitalized COVID-19 patients. Materials & methods: Data from …

American College of Rheumatology guidance for the management of rheumatic disease in adult patients during the COVID‐19 pandemic: version 3

TR Mikuls, SR Johnson, L Fraenkel… - Arthritis & …, 2021 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the management of adult
rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic …

Cardiac corrected QT interval changes among patients treated for COVID-19 infection during the early phase of the pandemic

GA Rubin, AD Desai, Z Chai, A Wang, Q Chen… - JAMA network …, 2021 - jamanetwork.com
Importance Critical illness, a marked inflammatory response, and viruses such as SARS-
CoV-2 may prolong corrected QT interval (QTc). Objective To evaluate baseline QTc interval …

Electrocardiographic features and outcome: Correlations in 124 hospitalized patients with COVID-19 and cardiovascular events

P Nathala, V Salunkhe, H Samanapally, Q Xu… - Journal of cardiothoracic …, 2022 - Elsevier
Objectives Electrocardiographic (ECG) changes have been associated with coronavirus
disease 2019 (COVID-19) severity. However, the progression of ECG findings in patients …

Myocardial injury in COVID-19 and its implications in short-and long-term outcomes

A Izquierdo-Marquisa, H Cubero-Gallego… - Frontiers in …, 2022 - frontiersin.org
COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still
a pandemic with high mortality and morbidity rates. Clinical manifestation is widely variable …

Combined effects of age and comorbidities on electrocardiographic parameters in a large non-selected population

P Giovanardi, C Vernia, E Tincani, C Giberti… - Journal of Clinical …, 2022 - mdpi.com
Background: Previous studies have evaluated average electrocardiographic (ECG) values
in healthy subjects or specific subpopulations. However, none have evaluated ECG average …

Electrocardiography on admission is associated with poor outcomes in coronavirus disease 2019 (COVID‐19) patients: A systematic review and meta‐analysis

MY Alsagaff, YH Oktaviono, BB Dharmadjati… - Journal of …, 2021 - Wiley Online Library
Background Electrocardiogram (ECG) is a widely accessible diagnostic tool that can easily
be obtained on admission and can reduce excessive contact with coronavirus disease 2019 …

The effect of cardiovascular disease and acute cardiac injury on fatal COVID-19: a meta-analysis

J Long, Y Luo, Y Wei, C Xie, J Yuan - The American journal of emergency …, 2021 - Elsevier
Background With the continuance of the global COVID-19 pandemic, cardiovascular
disease (CVD) and cardiac injury have been suggested to be risk factors for severe COVID …

QT Interval prolongation is a novel predictor of 1-year mortality in patients with COVID-19 infection

A Banai, Y Szekely, L Lupu, A Borohovitz… - Frontiers in …, 2022 - frontiersin.org
Background QT interval prolongation is common in critically ill patients and is associated
with increased mortality. However, the predictive value of a prolonged corrected QT interval …